✦ LIBER ✦

PL-2 A randomized phase III trial of adjuvant chemotherapy with UFT for completely resected pathological stage I (T1N0M0, T2N0M0) adenocarcinoma of the lung

✍ Scribed by Ohta, Morio; Kato, Harubumi; Hata, Enjyo; Tsubota, Noriaki; Hamajima, Nobuyuki; Saito, Yasuki; Wada, Hiromi; Suemasu, Keiichi; Ohta, Mitsuo

Book ID: 118571388
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 153 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)91655-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1078 A randomized phase III trial of adj

1078 A randomized phase III trial of adjuvant chemotherapy with UFT for completely resected pathological stage I (T1N0M0, T2N0M0) adenocarcinoma of the lung

✍ Hata, E.; Kato, H.; Ohta, M.; Tsubota, N.; Hamajima, N.; Saito, Y.; Wada, H.; Su 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 313 KB

A randomised controlled trial of pre-ope

A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer

✍ Stephens, Richard J.; Girling, David J.; Hopwood, Penelope; Thatcher, Nicholas 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 85 KB

A placebo-controlled randomized double-b

A placebo-controlled randomized double-blind study of adjuvant intrapleural BCG in patients with resected T1N0, T1N1, or T2N0 squamous cell carcinoma, adenocarcinoma, or large cell carcinoma of the lung: LCSG protocol 771

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 297 KB

5 Impact of surgical staging in evaluati

5 Impact of surgical staging in evaluating the radiotherapeutic outcome in RTOG #77-06, a phase III study for T1b-T2N0M0 prostatic carcinoma

✍ Sucha O. Asbell; R.J. Caplan; C.A. Perez; P. Rubin; R.L. Doggett; W.T. Sause; M. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Induction chemotherapy with MVP (mitomyc

Induction chemotherapy with MVP (mitomycin-C + vindesine + cisplatin) for stage III (T1-3, N2, M0) unresectable non-small cell lung cancer: The Toronto experience

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Induction chemotherapy with MVP (mitomyc

Induction chemotherapy with MVP (mitomycin-C + vindesine + cisplatin) for stage III (T1-3, N2, M0) unresectable non-small cell lung cancer: the Toronto experience

✍ Burkes, Ronald L.; Ginsberg, Robert J.; Shepherd, Frances A.; Blackstein, Martin 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 464 KB